Global Anti-inflammatory Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 92

Published Date: 05 Jun 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Anti-inflammatory Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Anti-inflammatory Therapeutics size is estimated to be USD 134430 million in 2026 from USD 107130 million in 2020, with a change XX% between 2020 and 2021. The global Anti-inflammatory Therapeutics market size is expected to grow at a CAGR of 5.8% for the next five years.

Market segmentation
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Anti-inflammatory Biologics
    Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Corticosteroids
    Others

Market segment by Application, can be divided into
    Arthritis
    Respiratory Diseases
    Dermatology
    Gastroenterology
    Others

Market segment by players, this report covers
    AbbVie
    Johnson & Johnson
    Amgen Inc
    AstraZeneca PLC
    Pfizer, Inc
    Novartis
    Roche
    Merck
    Sanofi
    GlaxoSmithKline
    Sun Pharmaceutical Industries Ltd
    TEVA

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Anti-inflammatory Therapeutics, with revenue, gross margin and global market share of Anti-inflammatory Therapeutics from 2019 to 2021.
Chapter 3, the Anti-inflammatory Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Anti-inflammatory Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Anti-inflammatory Therapeutics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Anti-inflammatory Therapeutics
    1.2 Classification of Anti-inflammatory Therapeutics by Type
        1.2.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2020
        1.2.3 Anti-inflammatory Biologics
        1.2.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
        1.2.5 Corticosteroids
        1.2.6 Others
    1.3 Global Anti-inflammatory Therapeutics Market by Application
        1.3.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Arthritis
        1.3.3 Respiratory Diseases
        1.3.4 Dermatology
        1.3.5 Gastroenterology
        1.3.6 Others
    1.4 Global Anti-inflammatory Therapeutics Market Size & Forecast
    1.5 Global Anti-inflammatory Therapeutics Market Size and Forecast by Region
        1.5.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Anti-inflammatory Therapeutics Market Size by Region, (2016-2021)
        1.5.3 North America Anti-inflammatory Therapeutics Market Size and Prospect (2016-2026)
        1.5.4 Europe Anti-inflammatory Therapeutics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Anti-inflammatory Therapeutics Market Size and Prospect (2016-2026)
        1.5.6 South America Anti-inflammatory Therapeutics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Anti-inflammatory Therapeutics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Anti-inflammatory Therapeutics Market Drivers
        1.6.2 Anti-inflammatory Therapeutics Market Restraints
        1.6.3 Anti-inflammatory Therapeutics Trends Analysis

2 Company Profiles
    2.1 AbbVie
        2.1.1 AbbVie Details
        2.1.2 AbbVie Major Business
        2.1.3 AbbVie Anti-inflammatory Therapeutics Product and Solutions
        2.1.4 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 AbbVie Recent Developments and Future Plans
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
        2.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Johnson & Johnson Recent Developments and Future Plans
    2.3 Amgen Inc
        2.3.1 Amgen Inc Details
        2.3.2 Amgen Inc Major Business
        2.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
        2.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Amgen Inc Recent Developments and Future Plans
    2.4 AstraZeneca PLC
        2.4.1 AstraZeneca PLC Details
        2.4.2 AstraZeneca PLC Major Business
        2.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
        2.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 AstraZeneca PLC Recent Developments and Future Plans
    2.5 Pfizer, Inc
        2.5.1 Pfizer, Inc Details
        2.5.2 Pfizer, Inc Major Business
        2.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
        2.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Pfizer, Inc Recent Developments and Future Plans
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Anti-inflammatory Therapeutics Product and Solutions
        2.6.4 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Novartis Recent Developments and Future Plans
    2.7 Roche
        2.7.1 Roche Details
        2.7.2 Roche Major Business
        2.7.3 Roche Anti-inflammatory Therapeutics Product and Solutions
        2.7.4 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Roche Recent Developments and Future Plans
    2.8 Merck
        2.8.1 Merck Details
        2.8.2 Merck Major Business
        2.8.3 Merck Anti-inflammatory Therapeutics Product and Solutions
        2.8.4 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Merck Recent Developments and Future Plans
    2.9 Sanofi
        2.9.1 Sanofi Details
        2.9.2 Sanofi Major Business
        2.9.3 Sanofi Anti-inflammatory Therapeutics Product and Solutions
        2.9.4 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Sanofi Recent Developments and Future Plans
    2.10 GlaxoSmithKline
        2.10.1 GlaxoSmithKline Details
        2.10.2 GlaxoSmithKline Major Business
        2.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
        2.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 GlaxoSmithKline Recent Developments and Future Plans
    2.11 Sun Pharmaceutical Industries Ltd
        2.11.1 Sun Pharmaceutical Industries Ltd Details
        2.11.2 Sun Pharmaceutical Industries Ltd Major Business
        2.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
        2.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
    2.12 TEVA
        2.12.1 TEVA Details
        2.12.2 TEVA Major Business
        2.12.3 TEVA Anti-inflammatory Therapeutics Product and Solutions
        2.12.4 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 TEVA Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Anti-inflammatory Therapeutics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Anti-inflammatory Therapeutics Players Market Share
        3.2.2 Top 10 Anti-inflammatory Therapeutics Players Market Share
        3.2.3 Market Competition Trend
    3.3 Anti-inflammatory Therapeutics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Anti-inflammatory Therapeutics Revenue and Market Share by Type (2016-2021)
    4.2 Global Anti-inflammatory Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2016-2021)
    5.2 Anti-inflammatory Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Anti-inflammatory Therapeutics Revenue by Type (2016-2026)
    6.2 North America Anti-inflammatory Therapeutics Revenue by Application (2016-2026)
    6.3 North America Anti-inflammatory Therapeutics Market Size by Country
        6.3.1 North America Anti-inflammatory Therapeutics Revenue by Country (2016-2026)
        6.3.2 United States Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        6.3.3 Canada Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        6.3.4 Mexico Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Anti-inflammatory Therapeutics Revenue by Type (2016-2026)
    7.2 Europe Anti-inflammatory Therapeutics Revenue by Application (2016-2026)
    7.3 Europe Anti-inflammatory Therapeutics Market Size by Country
        7.3.1 Europe Anti-inflammatory Therapeutics Revenue by Country (2016-2026)
        7.3.2 Germany Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        7.3.3 France Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        7.3.5 Russia Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        7.3.6 Italy Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2016-2026)
    8.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2016-2026)
    8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2016-2026)
        8.3.2 China Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        8.3.3 Japan Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        8.3.4 South Korea Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        8.3.5 India Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        8.3.7 Australia Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Anti-inflammatory Therapeutics Revenue by Type (2016-2026)
    9.2 South America Anti-inflammatory Therapeutics Revenue by Application (2016-2026)
    9.3 South America Anti-inflammatory Therapeutics Market Size by Country
        9.3.1 South America Anti-inflammatory Therapeutics Revenue by Country (2016-2026)
        9.3.2 Brazil Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        9.3.3 Argentina Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Anti-inflammatory Therapeutics Revenue by Type (2016-2026)
    10.2 Middle East & Africa Anti-inflammatory Therapeutics Revenue by Application (2016-2026)
    10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Revenue by Country (2016-2026)
        10.3.2 Turkey Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)
        10.3.4 UAE Anti-inflammatory Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Anti-inflammatory Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Anti-inflammatory Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Anti-inflammatory Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2021-2026)
    Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
    Table 7. AbbVie Major Business
    Table 8. AbbVie Anti-inflammatory Therapeutics Product and Solutions
    Table 9. AbbVie Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
    Table 11. Johnson & Johnson Major Business
    Table 12. Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
    Table 13. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Amgen Inc Corporate Information, Head Office, and Major Competitors
    Table 15. Amgen Inc Major Business
    Table 16. Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
    Table 17. Amgen Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. AstraZeneca PLC Corporate Information, Head Office, and Major Competitors
    Table 19. AstraZeneca PLC Major Business
    Table 20. AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
    Table 21. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Pfizer, Inc Corporate Information, Head Office, and Major Competitors
    Table 23. Pfizer, Inc Major Business
    Table 24. Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
    Table 25. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Novartis Corporate Information, Head Office, and Major Competitors
    Table 27. Novartis Major Business
    Table 28. Novartis Anti-inflammatory Therapeutics Product and Solutions
    Table 29. Novartis Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Roche Corporate Information, Head Office, and Major Competitors
    Table 31. Roche Major Business
    Table 32. Roche Anti-inflammatory Therapeutics Product and Solutions
    Table 33. Roche Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Merck Corporate Information, Head Office, and Major Competitors
    Table 35. Merck Major Business
    Table 36. Merck Anti-inflammatory Therapeutics Product and Solutions
    Table 37. Merck Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 39. Sanofi Major Business
    Table 40. Sanofi Anti-inflammatory Therapeutics Product and Solutions
    Table 41. Sanofi Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 43. GlaxoSmithKline Major Business
    Table 44. GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
    Table 45. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Sun Pharmaceutical Industries Ltd Corporate Information, Head Office, and Major Competitors
    Table 47. Sun Pharmaceutical Industries Ltd Major Business
    Table 48. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
    Table 49. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. TEVA Corporate Information, Head Office, and Major Competitors
    Table 51. TEVA Major Business
    Table 52. TEVA Anti-inflammatory Therapeutics Product and Solutions
    Table 53. TEVA Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Players (2019-2021)
    Table 55. Global Anti-inflammatory Therapeutics Revenue Share by Players (2019-2021)
    Table 56. Breakdown of Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 57. Anti-inflammatory Therapeutics Players Head Office, Products and Services Provided
    Table 58. Anti-inflammatory Therapeutics Mergers & Acquisitions in the Past Five Years
    Table 59. Anti-inflammatory Therapeutics New Entrants and Expansion Plans
    Table 60. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Type (2016-2021)
    Table 61. Global Anti-inflammatory Therapeutics Revenue Share by Type (2016-2021)
    Table 62. Global Anti-inflammatory Therapeutics Revenue Forecast by Type (2021-2026)
    Table 63. Global Anti-inflammatory Therapeutics Revenue by Application (2016-2021)
    Table 64. Global Anti-inflammatory Therapeutics Revenue Forecast by Application (2021-2026)
    Table 65. North America Anti-inflammatory Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 66. North America Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 67. North America Anti-inflammatory Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 68. North America Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 69. North America Anti-inflammatory Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 70. North America Anti-inflammatory Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 71. Europe Anti-inflammatory Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 72. Europe Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 73. Europe Anti-inflammatory Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 74. Europe Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 75. Europe Anti-inflammatory Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 76. Europe Anti-inflammatory Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 77. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 78. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 79. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 80. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 81. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2016-2021) & (USD Million)
    Table 82. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2021-2026) & (USD Million)
    Table 83. South America Anti-inflammatory Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 84. South America Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 85. South America Anti-inflammatory Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 86. South America Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 87. South America Anti-inflammatory Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 88. South America Anti-inflammatory Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 89. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 90. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 91. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 92. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 93. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 94. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Anti-inflammatory Therapeutics Picture
    Figure 2. Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2020
    Figure 3. Anti-inflammatory Biologics
    Figure 4. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Figure 5. Corticosteroids
    Figure 6. Others
    Figure 7. Anti-inflammatory Therapeutics Revenue Market Share by Application in 2020
    Figure 8. Arthritis Picture
    Figure 9. Respiratory Diseases Picture
    Figure 10. Dermatology Picture
    Figure 11. Gastroenterology Picture
    Figure 12. Others Picture
    Figure 13. Global Anti-inflammatory Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 14. Global Anti-inflammatory Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
    Figure 15. Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2016-2026)
    Figure 16. Global Anti-inflammatory Therapeutics Revenue Market Share by Region in 2020
    Figure 17. North America Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Europe Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Asia-Pacific Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. South America Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. Middle East and Africa Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Anti-inflammatory Therapeutics Market Drivers
    Figure 23. Anti-inflammatory Therapeutics Market Restraints
    Figure 24. Anti-inflammatory Therapeutics Market Trends
    Figure 25. AbbVie Recent Developments and Future Plans
    Figure 26. Johnson & Johnson Recent Developments and Future Plans
    Figure 27. Amgen Inc Recent Developments and Future Plans
    Figure 28. AstraZeneca PLC Recent Developments and Future Plans
    Figure 29. Pfizer, Inc Recent Developments and Future Plans
    Figure 30. Novartis Recent Developments and Future Plans
    Figure 31. Roche Recent Developments and Future Plans
    Figure 32. Merck Recent Developments and Future Plans
    Figure 33. Sanofi Recent Developments and Future Plans
    Figure 34. GlaxoSmithKline Recent Developments and Future Plans
    Figure 35. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
    Figure 36. TEVA Recent Developments and Future Plans
    Figure 37. Global Anti-inflammatory Therapeutics Revenue Share by Players in 2020
    Figure 38. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 39. Global Top 3 Players Anti-inflammatory Therapeutics Revenue Market Share in 2020
    Figure 40. Global Top 10 Players Anti-inflammatory Therapeutics Revenue Market Share in 2020
    Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 42. Global Anti-inflammatory Therapeutics Revenue Share by Type in 2020
    Figure 43. Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2021-2026)
    Figure 44. Global Anti-inflammatory Therapeutics Revenue Share by Application in 2020
    Figure 45. Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2021-2026)
    Figure 46. North America Anti-inflammatory Therapeutics Sales Market Share by Type (2016-2026)
    Figure 47. North America Anti-inflammatory Therapeutics Sales Market Share by Application (2016-2026)
    Figure 48. North America Anti-inflammatory Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 49. United States Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Canada Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Mexico Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Europe Anti-inflammatory Therapeutics Sales Market Share by Type (2016-2026)
    Figure 53. Europe Anti-inflammatory Therapeutics Sales Market Share by Application (2016-2026)
    Figure 54. Europe Anti-inflammatory Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 55. Germany Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. France Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. United Kingdom Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Russia Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Italy Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Type (2016-2026)
    Figure 61. Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Application (2016-2026)
    Figure 62. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Region (2016-2026)
    Figure 63. China Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Japan Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South Korea Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. India Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Southeast Asia Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Australia Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. South America Anti-inflammatory Therapeutics Sales Market Share by Type (2016-2026)
    Figure 70. South America Anti-inflammatory Therapeutics Sales Market Share by Application (2016-2026)
    Figure 71. South America Anti-inflammatory Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 72. Brazil Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Argentina Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Type (2016-2026)
    Figure 75. Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Application (2016-2026)
    Figure 76. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 77. Turkey Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Saudi Arabia Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. UAE Anti-inflammatory Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA

Related Reports

Global Anti-inflammatory Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Anti-inflammatory Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Medical Care

The Anti-inflammatory Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

anti inflammatory therapeutics

Anti-inflammatory Therapeutics

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>